Menu

Search

  |   Sports

Menu

  |   Sports

Search

Nicotine in sports: high use but little evidence of effects on performance

Premier league soccer players are some of the team sports athletes who actively use nicotine in competition. from www.shutterstock.com, CC BY-ND

0
comments

When you think nicotine, you probably think of smokers, addiction, carcinogens and disease - not elite athletes and sporting performance.

However, our research published today shows that the use of nicotine among athletes is high and increasing.

In some sports, up to half the team uses nicotine in various forms, mostly as smokeless chewing tobacco or nicotine patches and gum. This led the World Anti-Doping Agency to place nicotine on its monitoring programme in 2012, indicating that it could be upgraded to the list of banned substances.

We found little evidence of performance-lifting effects of nicotine use in most published studies.

Nicotine without smoke

Together with caffeine, nicotine is considered the most widely used psychoactive substance in the world. It is more potent and more addictive than caffeine.

In the sporting world, particularly in team sports, between a third and a half of professional athletes use nicotine. Sportspeople claim that it helps prevent a dry mouth, control body weight and improve concentration and attention.

Some chew tobacco in its moist form known as snus or inhale a dry powder called snuff. Others use nicotine patches, gum, nasal sprays, lozenges or tablets.

Keen soccer fans may remember media reports last year of Leicester City’s Jamie Vardy, after he was pictured in his England jersey, holding an energy drink and pouch of chewing tobacco. This is nothing unusual for America’s major league baseball fans who witness their idols chewing or dipping tobacco.

Snuff or snus: sportspeople use nicotine products that don’t require smoking. from www.shutterstock.com, CC BY-ND

Nicotine use in winter sports

Smokeless tobacco has been associated with baseball since its inception, and despite being replaced by smoking in the 1950s, returned in the late 1970s. By 2003, the number of major league players regularly using smokeless tobacco was 36 percent.

Ice-hockey is another sport where reports have emerged of 30 to 50 percent of players actively using nicotine. Other professional sports with higher than average (average being the roughly 25 percent worldwide prevalence of smoking tobacco) use of nicotine immediately before or during a game are reported by the Swiss Laboratory for Doping Analyses as American football, bobsleigh, gymnastics, rugby and skiing.

Research into nicotine so far has mostly centred on its pharmacodynamics and smoking cessation. Despite its widespread use among athletes, there has been little research into whether it does actually affect sporting performance, and none into whether it can pose a health risk to this population.

Performance effects

In our research we have excluded studies that involved tobacco smoking or smokers. The rationale was that we already known that smoking kills about six million people worldwide each year, and that smoked tobacco reduces aerobic and muscular performance. Considerably fewer elite athletes smoke, compared to the general population.

The majority of the ten studies that investigated nicotine use in athletes found no effect on performance (either good or bad). However, two of the five studies that tested nicotine in patches and gum found that it improved exercise endurance and muscular strength. Also interesting was that of the five studies that reported negative side effects with nicotine (e.g. coughing, sneezing, sore throat, increased heart rate, nausea and dizziness), none reduced exercise performance, and two of these actually found improved performance.

The unknowns of nicotine use

It is what hasn’t been tested yet that is probably more worthwhile thinking about. For example, unless you are a current tobacco user, you would be pharmacologically naïve to the drug and your body would respond quite differently to the regular user.

Many athletes stick to the mantra that if some is good, more is better, but with nicotine this could have the opposite effect. At lower doses it acts as a stimulant, but at higher doses it can be a depressant.

Women appear to metabolise nicotine faster than men and some ethnic differences have also been reported. The different ways nicotine can be consumed can also have consequences on how much nicotine is absorbed, or how long it stays in your system.

Some serious unknowns remain regarding long-term use and both mental and physical health. There is some evidence of increased risk to developing cardiovascular and metabolic diseases, promoting tumours and impaired wound healing. Nicotine use also occurs concurrently with several mental health disorders.

More evidence needed

Nicotine’s legal status for athletes is currently clear: it is not prohibited. The World Anti-Doping Agency is monitoring its use by athletes, presumably to determine whether there is potential for misuse and to determine whether its use could be altering the spirit of sports.

Certainly, more research is needed to determine the effect of nicotine on athletes in terms of performance enhancement, and health and wellbeing. However, there’s an interesting philosophical and ethical question about who should be funding and driving such research.

Should it be tobacco companies, which have effectively created and cultivated a nicotine-fueled problem, or the pharmaceutical companies that profit handsomely from trying to remedy the effects of tobacco use?

One thing remains clear with regards to nicotine and its use in sports: more evidence is required before anti-doping and governing bodies could consider promoting, coordinating and monitoring any effort against nicotine-containing substances.

The ConversationToby Mündel has received funding from the World Anti-Doping Agency, The Physiological Society and The Maurice and Phyllis Paykel Trust to support nicotine-related research and travel to present this research at conferences.

  • ET PRO
  • Market Data

Market-moving news and views, 24 hours a day >

September 20 15:30 UTC Released

BRForeign Exchange Flows*

Actual

2.161 Bln USD

Forecast

Previous

-1.251 Bln USD

September 20 14:30 UTC Released

TRCentral Govt Debt Stock*

Actual

820.5 Bln TRY

Forecast

Previous

817.1 Bln TRY

September 21 08:30 UTC 430430m

GBPSNB, MM GBP

Actual

Forecast

Previous

-0.76 Bln GBP

September 21 08:30 UTC 430430m

GBPSNCR, MM GBP

Actual

Forecast

Previous

-3.912 Bln GBP

September 21 08:30 UTC 430430m

GBPSNB Ex Banks GBP

Actual

Forecast

7.100 Bln GBP

Previous

-0.184 Bln GBP

September 21 12:00 UTC 640640m

BRIPCA-15 Mid-Month CPI

Actual

Forecast

0.15 %

Previous

0.35 %

September 21 12:00 UTC 640640m

BRIPCA-15 Mid-Month CPI YY*

Actual

Forecast

2.60 %

Previous

2.68 %

September 21 12:30 UTC 670670m

CAWholesale Trade MM

Actual

Forecast

-0.9 %

Previous

-0.5 %

September 21 12:30 UTC 670670m

USInitial Jobless Claims

Actual

Forecast

300 k

Previous

284 k

September 21 12:30 UTC 670670m

USJobless Claims 4-Wk Avg

Actual

Forecast

Previous

263.25 k

Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.